Merck KGaA (MRKd)

FRAHealthcare

€109.8
-€0.1 (-0.1%)
Market closed

April 2, 2026 at 16:30 UTC

Interactive Chart

MRKd
1H
3H
6H
12H
1D
1W
1M
3M
6M
1Y
2Y
5Y
All

13:46:16 UTC

About Merck KGaA

Name
Merck KGaA
CEO
Belen Garijo Lopez
Industry
Healthcare
Year Founded
1668
Employees
59,020

Merck KGaA is a science and technology company active in life science tools, healthcare, and advanced materials. The unifying idea is method: design processes that researchers, clinicians, and manufacturers can repeat with confidence, then supply the instruments, reagents, therapies, and specialty materials that keep those processes on plan. In laboratories, the brand is associated with clean documentation and support that respects how experiments actually run. In healthcare, development and medical guidance focus on safe use in real clinics, not only in papers. In electronics, materials are delivered with traceability that device makers can audit. Country teams adapt to local rules while holding to common standards. Within the healthcare and technology ecosystem, the group presents itself as infrastructure for discovery and production, linking disciplined science with delivery that works on busy days as well as calm ones.

Analyst Ratings

Consensus Recommendation
Analyst consensus: 5 Buy, 11 Hold, 7 Sell
Buy5
Hold11
Sell7

Fundamentals & Financials

Revenue (TTM)
€21.1B
Net Income (TTM)
€2.6B
EPS (TTM)
€5.99
ROA (TTM)
5.01%
Current Ratio
1.46
Dividend Yield
0.097%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

ItemQ4 2025
Revenue€5,249M
Cost of Sales€2,288M
Gross Profit€2,961M
Operating Income€781,000K
Net Income€319,000K
EPS€0.73

Technical Indicators

Merck KGaA's Technical Indicators Summary

MRKd presents a conflicted technical picture that leaves the tape neutral. ADX is elevated, suggesting an established trend, yet short‑term momentum is mixed with modest RSI and a small positive momentum reading while the MACD is negative. The market sits near its 10–20 averages but remains below multiple longer EMAs, indicating shorter‑term strength against longer‑term resistance. Volatility is moderate and on‑balance volume is negative, which undercuts recent gains. Technical takeaway: Neutral — short‑term moving averages show support but longer EMAs and volume weigh on conviction.

Buy
5 signals
Neutral
11 signals
Sell
7 signals
Overall: Neutral48% Neutral signals
IndicatorValue
RSI (14)
46.37
Stochastic %K (14, 3, 3)
78.14
CCI (20)
31.40
WPR (14)
-15.35
Momentum (10)
2.45
MFI
38.66
MACD Level (12, 26)
-3.04
Bollinger Bands
$102.77 - $112.81
ATR (14)
$3.12 (2.85%)
ADX (14)
32.80
OBV
-5,477,095
Classic Pivot Point
$109.83
Fibonacci Pivot Point
$109.83
Exponential Moving Averages
$107.96 - $116.88(5 indicators)
Simple Moving Averages
$106.30 - $118.31(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

The session wrapped with MRKd mildly under yesterday, as the -0.55% gap down left it closing around 109.30. End-of-day, the peer group was roughly unchanged (-0.06%), limiting broader influence on MRKd. MRKd edged lower after a mild gap-down, with peers flat and no broader sector impulse.

Price Change

from €109.8 close

-€0.65

Trading Volume

Below avg (401.0K)

165.5K

vs S&P 500 Today

Underperforming Market

-0.66%

52-Week Position

Lower range

27.8%

Updated: April 2, 2026 at 15:03 UTC

Quote Summary

OpenPrevious Close
€107.9€109.8
Day Range52 Week Range
€106.55 - €109.8€100.7 - €131.65
VolumeAvg. Volume
361.9K341.9K
Market CapP/E Ratio
€47.7B18.3